3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hematologic Neoplasms
3
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hodgkin Disease
2
Multiple Myeloma
1
Cytomegalovirus Infections
1
Interventions
ruxolitinib
3
venetoclax
2
fludarabine phosphate
2
duvelisib
2
thymoglobulin
1
romidepsin
1
itacitinib
1
fludarabine
1
Whole-Body Irradiation
1
Stem Cell Transplantation
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Lisaftoclax
1
Depsipeptides
1
Cyclosporins
1
Cyclosporine
1
Cladribine
1
Busulfan
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Prolymphocytic, T-Cell
×
letermovir
×
1 year
×
Clear all
No trials found.